These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36365185)

  • 41. Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs.
    Blotière PO; Raguideau F; Weill A; Elefant E; Perthus I; Goulet V; Rouget F; Zureik M; Coste J; Dray-Spira R
    Neurology; 2019 Jul; 93(2):e167-e180. PubMed ID: 31189695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Empirical models for anatomical and physiological changes in a human mother and fetus during pregnancy and gestation.
    Kapraun DF; Wambaugh JF; Setzer RW; Judson RS
    PLoS One; 2019; 14(5):e0215906. PubMed ID: 31048866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy.
    Voinescu PE; Park S; Chen LQ; Stowe ZN; Newport DJ; Ritchie JC; Pennell PB
    Neurology; 2018 Sep; 91(13):e1228-e1236. PubMed ID: 30185446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant Women.
    Dallmann A; Solodenko J; Ince I; Eissing T
    CPT Pharmacometrics Syst Pharmacol; 2018 Jul; 7(7):419-431. PubMed ID: 29569837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.
    Veroniki AA; Rios P; Cogo E; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
    BMJ Open; 2017 Jul; 7(7):e017248. PubMed ID: 28729328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.
    Antunes NJ; van Dijkman SC; Lanchote VL; Wichert-Ana L; Coelho EB; Alexandre Junior V; Takayanagui OM; Tozatto E; van Hasselt JGC; Della Pasqua O
    Eur J Pharm Sci; 2017 Nov; 109S():S116-S123. PubMed ID: 28528287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.
    Dallmann A; Ince I; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Nov; 56(11):1303-1330. PubMed ID: 28401479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
    Zhang Z; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploration of PBPK Model-Calculation of Drug Time Course in Tissue Using IV Bolus Drug Plasma Concentration-Time Profile and the Physiological Parameters of the Organ.
    Berezhkovskiy LM
    J Pharm Sci; 2016 Aug; 105(8):2453-8. PubMed ID: 27290628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
    De Sousa Mendes M; Hirt D; Vinot C; Valade E; Lui G; Pressiat C; Bouazza N; Foissac F; Blanche S; Lê MP; Peytavin G; Treluyer JM; Urien S; Benaboud S
    Br J Clin Pharmacol; 2016 Apr; 81(4):646-57. PubMed ID: 26518984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man.
    Malátková P; Havlíková L; Wsól V
    Chem Biol Interact; 2014 Sep; 220():241-7. PubMed ID: 25063510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of antiepileptic drugs in pregnancy.
    Sabers A; Petrenaite V
    Expert Rev Clin Pharmacol; 2008 Jan; 1(1):129-36. PubMed ID: 24410516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of physiologically based pharmacokinetic modeling in regulatory review.
    Huang SM; Rowland M
    Clin Pharmacol Ther; 2012 Mar; 91(3):542-9. PubMed ID: 22318616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: application to dibenz[b,f]azepine-5-carboxamide derivatives.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    J Pharm Sci; 2012 Feb; 101(2):530-40. PubMed ID: 22052653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Jan; 99(1):475-85. PubMed ID: 19492340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurologic birth defects after prenatal exposure to antiepileptic drugs.
    Uziel D; Rozental R
    Epilepsia; 2008 Dec; 49 Suppl 9():35-42. PubMed ID: 19087116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.